Mettler-Toledo International (NYSE:MTD) had its price target decreased by Morgan Stanley from $595.00 to $568.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an equal weight rating on the medical instruments supplier’s stock.
MTD has been the subject of several other research reports. Citigroup upgraded shares of Mettler-Toledo International from a neutral rating to a buy rating and lifted their price objective for the stock from $685.00 to $692.00 in a research note on Friday, February 9th. Barclays began coverage on shares of Mettler-Toledo International in a research note on Thursday, January 4th. They issued an equal weight rating and a $625.00 price objective for the company. Goldman Sachs cut shares of Mettler-Toledo International from a buy rating to a neutral rating in a research note on Monday, April 9th. Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $675.00 to $630.00 and set a neutral rating for the company in a research note on Friday, February 9th. Finally, Evercore ISI began coverage on shares of Mettler-Toledo International in a research note on Wednesday, January 3rd. They issued an in-line rating and a $625.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Mettler-Toledo International presently has an average rating of Hold and a consensus target price of $641.00.
NYSE MTD opened at $568.21 on Wednesday. The company has a quick ratio of 1.09, a current ratio of 1.46 and a debt-to-equity ratio of 1.75. The stock has a market cap of $14,513.41, a PE ratio of 32.34, a P/E/G ratio of 2.23 and a beta of 1.20. Mettler-Toledo International has a 52-week low of $473.55 and a 52-week high of $697.26.
Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 8th. The medical instruments supplier reported $5.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.93 by $0.04. The company had revenue of $778.03 million during the quarter, compared to analysts’ expectations of $764.26 million. Mettler-Toledo International had a net margin of 13.80% and a return on equity of 94.54%. Mettler-Toledo International’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the company posted $5.28 EPS. equities research analysts expect that Mettler-Toledo International will post 20.24 earnings per share for the current year.
In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $605.20, for a total value of $181,560.00. Following the transaction, the chief financial officer now directly owns 5,599 shares of the company’s stock, valued at approximately $3,388,514.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider La Guerroniere Marc De sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $640.00, for a total transaction of $1,920,000.00. Following the completion of the transaction, the insider now directly owns 3,000 shares in the company, valued at $1,920,000. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,268 shares of company stock worth $17,497,059. Insiders own 4.80% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in Mettler-Toledo International by 2.3% in the 4th quarter. BlackRock Inc. now owns 1,847,591 shares of the medical instruments supplier’s stock valued at $1,144,617,000 after buying an additional 41,344 shares during the period. Goldman Sachs Group Inc. increased its holdings in Mettler-Toledo International by 0.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 482,730 shares of the medical instruments supplier’s stock valued at $299,061,000 after buying an additional 3,876 shares during the period. Russell Investments Group Ltd. increased its holdings in Mettler-Toledo International by 2.5% in the 4th quarter. Russell Investments Group Ltd. now owns 328,763 shares of the medical instruments supplier’s stock valued at $204,608,000 after buying an additional 7,996 shares during the period. Geode Capital Management LLC increased its holdings in Mettler-Toledo International by 3.5% in the 4th quarter. Geode Capital Management LLC now owns 305,818 shares of the medical instruments supplier’s stock valued at $189,106,000 after buying an additional 10,258 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its holdings in Mettler-Toledo International by 23.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 226,432 shares of the medical instruments supplier’s stock valued at $140,279,000 after buying an additional 43,665 shares during the period. 92.45% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/14/morgan-stanley-trims-mettler-toledo-international-mtd-target-price-to-568-00.html.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.